Navigation Links
Small RNA plays parallel roles in bacterial metabolism
Date:11/29/2007

They are often overlooked, and were once thought to be too small to contribute much to major cellular processes, but in recent years the study of small ribonucleic acids (sRNA) has gained momentum. Now a team from the University of Illinois has identified the unique metabolic activities of one of these bit players, a 200-nucleotide-long RNA molecule in bacteria called SgrS.

This molecule is one of about 80 known small RNAs common to many bacteria. It got its name for its role in sugar metabolism (SgrS is an acronym for sugar-related stress). When a bacterium such as Escherichia coli has taken up enough or too much glucose from its surroundings, SgrS helps stop the transport of glucose molecules across the cell membrane, said microbiology professor and principal investigator Carin Vanderpool.

In trying to tease out how SgrS performs this task, Vanderpool and technician Caryn Wadler discovered that the molecule performs dual roles, both of which inhibit the transport of glucose into the cell. One region of the RNA molecule binds to a messenger RNA to inhibit the production of new glucose transporters, while another region codes for a protein that seems to retard the activity of existing transporters.

The findings appear online this month in the Proceedings of the National Academy of Sciences.

The most novel thing about this discovery is that this molecule seems to be truly bi-functional in that the two functions it performs participate in the same stress response, Vanderpool said.

One other small RNA, a 500-nucleotide molecule that regulates virulence genes in Staphylococcus aureus bacteria, was previously found to encode a protein, Vanderpool said, but the activity of that protein did not participate in the regulation.

The two regions of the molecule were apparently engaged in unrelated tasks.

Some glucose is obviously good, since the bacteria use it to make essential cell molecules and to prov
'/>"/>

Contact: Diana Yates
diya@uiuc.edu
217-333-5802
University of Illinois at Urbana-Champaign  
Source:Eurekalert

Page: 1 2

Related biology news :

1. Social parasites of the smaller kind
2. Small animal imaging facility is big boon to research
3. Handbook of small grain insects available now
4. New molecular clock from LLNL and CDC indicates smallpox evolved earlier than believed
5. 2007 ozone hole smaller than usual
6. Cilia: small organelles, big decisions
7. Research shows loggerhead sea turtles threatened by small-scale fishing operations
8. Small-scale fishing in Mexico rivals industrial fisheries in accidental turtle deaths
9. Sweet potato shines as new promise for small enterprise and hunger relief in developing countries
10. Identification of a novel class of (not-so) small RNAs
11. Speed plays crucial role in breaking proteins H-bonds

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Small RNA plays parallel roles in bacterial metabolism
Small RNA plays parallel roles in bacterial metabolism
(Date:11/9/2009)...ADELPHIA, NOVEMBER 9, 2009 A nutritionist whose ...etables to the federal Women, Infants and Children...s Agnes Higgins Award for outstanding achievement ...il Harrison, Ph.D., MNS, , a professor in the Depa...ity of California, Los Angeles School of Public He...
(Date:11/8/2009)...HEALTH EDUCATION DESIGNED FOR ADULTS WITH INTELLEC...VES , An Indiana University study involving adu...adults increased their personal health knowledge a..., Adults with ID, an internationally accepted ter...es of obesity, physical inactivity and preventable...
(Date:11/6/2009)...-dwelling ants generally live in harmony with thei...hen they run out of space in their trees of choice...s. , The research, published in the November iss...ocument that ants bore into live trees, and it reo...tween ants and plants. , Ants and certain specie...
Breaking Biology News(10 mins):March of Dimes honors Dr. Gail Harrison for outstanding work in maternal-fetal nutrition 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Ants are friendly to some trees, but not others 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 1Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 2Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzal 28R 29 Solution and Announcement of Lawsuit by Sepracor UCB 49926 3Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 1Conceive Introduces New MyConceive Online Community for Women Seeking to Get Pregnant 49921 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 1Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 2Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 3Preclinical Proof of Concept Studies Published for Novavax Seasonal Influenza Virus Like Particle Vaccine 12765 4
... in German . , DNA, the molecule that acts as ... life, is highly resistant against alteration by u...for its photostability presents some puzzling prob...four chemical bases that make up the DNA molecule....showing that DNA strands differ in their light sen...
...tion to the IOF World Congress on Osteoporosis 200...until October 31, 2008. , To benefit from lower ...www.iofbonehealth.org/wco/2008/homepage.html . Sp...ants from non-OECD countries and for IOF members. ...at higher rates, will be possible. , Your chance...
..., Inc. (Nasdaq:,AWRE), a leading supplier of broad...led a conference call to discuss the company,s ope...ursday, October 23, 2008, at 5:00 p.m.,Eastern Tim...st the,earnings conference call., This call is be...Investor Relations page of our website at http://...
Other Biology News:Can genetic information be controlled by light? 2Aware Announces Q3 2008 Earnings Conference Call 2
(Date:11/6/2009)...NNA, Austria, November 6 EUCODIS B...facturing, and marketing enzymes for the,chemical ...a research,agreement with Bio Sidus, the leading b... The agreement gives EUCODIS Bioscience exclusi...- to Bio Sidus, proprietary collection of,psychrop...
(Date:11/6/2009)..., Calif., Nov. 6 Intarcia Therapeu...s ITCA 650 (DUROS® continuous delivery of exe...es at the Ninth Annual Diabetes Technology Meeting...wscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...Via ITCA 650 Lowers Plasma Glucose, HbA1c and Redu...
(Date:11/5/2009)...TON, Colo., Nov. 5 The endangered ...the western U.S. This rare carnivore feeds on pra... to plague and often entire population die-offs in...e (FWS) has implemented a ferret breeding program ...to their formerly native habitat. Unfortunately, ...
(Date:11/5/2009)...nce Call on Thursday, November 5, 2009 at 4:30 p.m...v. 5 /PRNewswire-FirstCall/ - OncoGenex Pharmaceut...: OGXI ) today reported unaudited financial resul...tember 30, 2009 and reviewed the Company,s highlig...wing consolidated results reflect the operations o...
Breaking Biology Technology:EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...XEL International Corporation (Nasdaq: PRXL ), a...r, will address important industry issues at the D...Meeting, being held from March 23 - 25, 2009 in Be...rs will present on topics ranging from global bios...mbination products, and clinical process validatio...
...stCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ:...results for the fourth quarter and year ended Dece...les results in our Medical Products Business and w... new technology initiatives despite a challenging ...t and CEO of Angiotech. "Not only did we increase ...
...nd AMSTERDAM, March 5 ,Agendia, a world leader in ...appointment of Dr. Albert A. (Al) Luderer to its S...30 years of experience in in vitro medical,diagnos...ent. Currently, he,is the Chief Executive Officer ...y using innovative platform technologies to dramat...
Other Biology Technology:PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 2PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 3PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 4PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 2Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 3Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 4Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 5Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 6Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 7Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 8Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 9Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 10Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 11Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 12Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 13Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 14Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 15Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 16Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 17Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 18Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 19Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 20Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 21Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 22Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 23Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 24Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 25Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 26Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 27Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008 28Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board 2
AC1 Auto System, BioChemi™ Camera from UVP
Rabbit Anti-Pendrin (H-195) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
GeneAmp AccuRT RNA PCR Kit with Controls from Applied Biosystems
Mouse Anti-Human HLA-DRbeta Monoclonal Antibody, Unconjugated, Clone DA2 from Santa Cruz Biotechnology, Inc.
Biology Products: